The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status.

Zesiewicz, Theresa A; Wecker, Lynn; Sullivan, Kelly L; Merlin, Lisa R; Hauser, Robert A

Zesiewicz, Theresa A; Wecker, Lynn; Sullivan, Kelly L; Merlin, Lisa R; Hauser, Robert A.

Affiliation

Zesiewicz TA; Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, 33612, USA. tzesiewi@hsc.usf.edu

Clin Neuropharmacol ; 29(3): 106-11, 2006.

Article in En | MEDLINE | ID: mdl-16772808

Subject(s)

Catechols/therapeutic use; Homocysteine/blood; Levodopa/therapeutic use; Parkinson Disease/blood; Vitamins/blood; Catechol O-Methyltransferase/blood; Catechol O-Methyltransferase Inhibitors; Drug Therapy, Combination; Folic Acid/blood; Humans; Levodopa/adverse effects; Nitriles; Parkinson Disease/drug therapy; Randomized Controlled Trials as Topic; Vitamin B 12/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Vitamins / Levodopa / Catechols / Homocysteine Type of study: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Clin Neuropharmacol Year: 2006 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links